Photo by camstejim from unsplash
Two recent, randomized, placebo‐controlled phase II/III trials (clinicaltrials.gov: NCT01110720, NCT01049399) of davunetide and tideglusib in progressive supranuclear palsy (PSP) generated prospective, 1‐year longitudinal datasets of high‐resolution T1‐weighted three‐dimensional MRI. Click to show full abstract
Two recent, randomized, placebo‐controlled phase II/III trials (clinicaltrials.gov: NCT01110720, NCT01049399) of davunetide and tideglusib in progressive supranuclear palsy (PSP) generated prospective, 1‐year longitudinal datasets of high‐resolution T1‐weighted three‐dimensional MRI.
Keywords:
longitudinal magnetic;
resonance imaging;
supranuclear palsy;
magnetic resonance;
imaging progressive;
progressive supranuclear
Journal Title: Movement Disorders
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Movement Disorders
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!